![]() |
![]() |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Attacking the label bottleneck: tools and strategies for a best in class approach |
||
Led by: Ann McAlinden, Project Manager and James McAleavey, Label Control Manager, ALMAC |
||
| About the Workshop | ||
A common issue for both large and small Pharma alike involves the label production process for IMP’s, their generation and approval. This traditionally can be a bottleneck that can affect trial start dates. Almac Clinical Services present a non-proprietary workshop that examines the nature of clinical trial labels, difficulties that arise and potential uses of technology to overcome these obstacles. Attendees can also learn about a Business Project Management approach to innovation and improving the clinical supply chain. |
||
| Agenda | ||
| 9:30 | Delegate registration and coffee | |
| 10:00 | The label generation process for IMPs
|
|
11.00 |
Using technology to improve the process – a business project perspective
|
|
12.00 |
Successful solutions to the IMP label bottleneck
|
|
| 13:00 | Close of workshop | |
| About Your Workshop Leader | ||
| Ann McAlinden Global Business Project Manager Almac |
Ann McAlinden is a Global Business Project Manager within Almac Clinical Services, with over 10 years experience in validation, quality and project management. Ann successfully led the team that developed and launched the industry’s first automated label verification system. | |
| James McAleavey Label Control Manager Almac |
James McAleavey is the Label Control Manager within Almac Clinical Services. James has overseen the introduction of automation within the labelling process and has many years experience of managing the label generation and printing function within Almac. | |
|
||
